Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy

Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy

US Patent 9108980 · Granted Aug 18, 2015

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy2025
Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy2023
FGFR kinase inhibitors and pharmaceutical uses2021
Tricyclic heterocyclic derivatives and uses thereof2021
Tricyclic heterocyclic derivatives and uses thereof2021
Tricyclic heterocyclic derivatives and uses thereof2021
Organic electroluminescent materials and devices2021
Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy2021
1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate com2020
1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate com2020
1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate com2019
1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate com2019